Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Ditlev, Sisse B ^a,b   Florea, Raluca ^c,d   Nielsen, Morten A ^a,b   Theander, Thor G ^a,b   Magez, Stefan ^c,d   Boeuf, Philippe ^e,f   Salanti, Ali ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN 4 SULFATE; EPITOPE; IMMUNOGLOBULIN G; MICROORGANISM PROTEIN; NANOBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VAR2CSA PROTEIN;

ANTIBODY COMBINING SITE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; IMMUNOREACTIVITY; MALARIA; MOLECULAR RECOGNITION; NANOTECHNOLOGY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TARGETING; SCREENING TEST;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, PROTOZOAN; CAMELIDS, NEW WORLD; CHONDROITIN SULFATES; EPITOPES; ERYTHROCYTES; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PLASMODIUM FALCIPARUM; PROTEIN BINDING; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SINGLE-DOMAIN ANTIBODIES;

EID: 84898622899     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084981     Document Type: Article

References (37)

1. Achur RN, Valiyaveettil M, Alkhalil A, Ockenhouse CF, Gowda DC (2000) Characterization of proteoglycans of human placenta and identification of unique chondroitin sulfate proteoglycans of the intervillous spaces that mediate the adherence of Plasmodium falciparum-infected erythrocytes to the placenta. J Biol Chem 275: 40344-40356. 10.1074/jbc.M006398200 [doi];M006398200 [pii].
2. Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP et al. (2003) Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 49: 179-191. 3570 [pii].
3. Cham GK, Turner L, Kurtis JD, Mutabingwa T, Fried M et al. (2010) Hierarchical, domain type-specific acquisition of antibodies to Plasmodium falciparum erythrocyte membrane protein 1 in Tanzanian children 10. Infect Immun 78: 4653-4659. IAI.00593-10 [pii];10.1128/IAI.00593-10 [doi].
4. Boeuf P, Aitken EH, Chandrasiri U, Chua CL, McInerney B et al. (2013) Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport 7. PLoS Pathog 9: e1003153. 10.1371/journal.ppat. 1003153 [doi];PPATHOGENS-D-12-01766 [pii].
5. Brabin BJ, Romagosa C, Abdelgalil S, Menendez C, Verhoeff FH et al. (2004) The sick placenta-the role of malaria. Placenta 25: 359-378. 10.1016/j.placenta.2003.10.019 [doi];S0143400403003072 [pii].
6. Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L et al. (2004) Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 200: 1197-1203. (Pubitemid 39507059)
7. Duffy PE, Fried M (2003) Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 71: 6620-6623. (Pubitemid 37337723)
8. Trimnell AR, Kraemer SM, Mukherjee S, Phippard DJ, Janes JH et al. (2006) Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria. Mol Biochem Parasitol 148: 169-180. S0166-6851(06)00110-1 [pii];10.1016/j.molbiopara.2006.03.012 [doi].
9. Andersen P, Nielsen MA, Resende M, Rask TS, Dahlback M et al. (2008) Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA. PLoS Pathog 4: e42. 07-PLPA-RA-0432 [pii];10.1371/journal.-ppat.0040042 [doi].
10. Bockhorst J, Lu F, Janes JH, Keebler J, Gamain B et al. (2007) Structural polymorphism and diversifying selection on the pregnancy malaria vaccine candidate VAR2CSA. Mol Biochem Parasitol 155: 103-112. S0166-6851(07)00163-6 [pii];10.1016/j.molbiopara.2007.06.007 [doi].
11. Nielsen MA, Pinto VV, Resende M, Dahlback M, Ditlev SB et al. (2009) Induction of adhesion-inhibitory antibodies against placental Plasmodium falciparum parasites by using single domains of VAR2CSA. Infect Immun 77: 2482-2487. IAI.00159-09 [pii];10.1128/IAI.00159-09 [doi].
12. Obiakor H, Avril M, Macdonald NJ, Srinivasan P, Reiter K et al. (2013) Identification of VAR2CSA domain-specific inhibitory antibodies of the Plasmodium falciparum erythrocyte membrane protein 1 using a novel flow cytometry assay 4. Clin Vaccine Immunol 20: 433-442. CVI.00638-12 [pii];10.1128/CVI.00638-12 [doi].
13. Avril M, Cartwright MM, Hathaway MJ, Smith JD (2011) Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins. Malar J 10: 36. 1475-2875-10-36 [pii];10.1186/1475- 2875-10-36 [doi].
14. Fried M, Avril M, Chaturvedi R, Fernandez P, Lograsso J et al. (2013) Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria 12. Infect Immun 81: 487-495. IAI.01106-12 [pii];10.1128/IAI.01106-12 [doi].
15. Magistrado PA, Minja D, Doritchamou J, Ndam NT, John D et al. (2011) High efficacy of anti DBL4varepsilon-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. Vaccine 29: 437-443. S0264-410X(10)01593-8 [pii];10.1016/j.vaccine.2010.10.080 [doi].
16. Fernandez P, Petres S, Mecheri S, Gysin J, Scherf A (2010) Strain-transcendent immune response to recombinant Var2CSA DBL5-epsilon domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions 15. PLoS One 5: e12558. 10.1371/journal.pone.0012558 [doi].
17. Fernandez P, Viebig NK, Dechavanne S, Lepolard C, Gysin J et al. (2008) Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites. Malar J 7: 170. 1475-2875-7-170 [pii];10.1186/1475-2875-7-170 [doi].
18. Dahlback M, Jorgensen LM, Nielsen MA, Clausen TM, Ditlev SB et al. (2011) The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains. J Biol Chem 286: 15908-15917. M110.191510 [pii];10.1074/jbc.M110.191510 [doi].
19. Srivastava A, Gangnard S, Dechavanne S, Amirat F, Lewit BA et al. (2011) Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region. PLoS One 6: e20270. 10.1371/journal.pone.0020270 [doi];PONE-D-11-03862 [pii].
20. Clausen TM, Christoffersen S, Dahlback M, Langkilde AE, Jensen KE et al. (2012) Structural and Functional Insight Into How the Plasmodium falciparum VAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria 18. J Biol Chem. M112.348839 [pii];10.1074/jbc.M112.348839 [doi].
21. Barfod L, Bernasconi NL, Dahlback M, Jarrossay D, Andersen PH et al. (2007) Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSA. Mol Microbiol 63: 335-347. MMI5503 [pii];10.1111/j.1365-2958.2006.05503.x [doi]. (Pubitemid 46058923)
22. Tutterrow YL, Avril M, Singh K, Long CA, Leke RJ et al. (2012) High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission 19. Infect Immun 80: 1479-1490. IAI.00071-12 [pii];10.1128/IAI.00071-12 [doi].
23. Muyldermans S (2001) Single domain camel antibodies: current status. J Biotechnol 74: 277-302. S1389-0352(01)00021-6 [pii].
24. De Genst EJ, Guilliams T, Wellens J, O'Day EM, Waudby CA et al. (2010) Structure and properties of a complex of alpha-synuclein and a single-domain camelid antibody 26. J Mol Biol 402: 326-343. S0022-2836(10)00742-4 [pii];10.1016/j.jmb.2010.07.001 [doi].
25. Stijlemans B, Conrath K, Cortez-Retamozo V, Van XH, Wyns L, et al. (2004) Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem 279: 1256-1261. 10.1074/jbc.M307341200 [doi];M307341200 [pii].
26. Muyldermans S, Baral TN, Retamozzo VC, De BP, De GE, et al. (2009) Camelid immunoglobulins and nanobody technology 106. Vet Immunol Immunopathol 128: 178-183. S0165-2427(08)00401-7 [pii];10.1016/j.vetimm.2008.10.299 [doi].
27. Saerens D, Conrath K, Govaert J, Muyldermans S (2008) Disulfide bond introduction for general stabilization of immunoglobulin heavy-chain variable domains 59. J Mol Biol 377: 478-488. S0022-2836(08)00040-5 [pii];10.1016/j.jmb. 2008.01.022 [doi].
28. Harmsen MM, de Haard HJ (2007) Properties, production, and applications of camelid single-domain antibody fragments. Appl Microbiol Biotechnol 77: 13-22. 10.1007/s00253-007-1142-2 [doi]. (Pubitemid 47573319)
29. Barfod L, Dobrilovic T, Magistrado P, Khunrae P, Viwami F et al. (2010) Chondroitin sulfate A-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants. J Immunol 185: 7553-7561. jimmunol.1002390 [pii];10.4049/jimmunol. 1002390 [doi].
30. Minaeian S, Rahbarizadeh F, Zarkesh-Esfahani SH, Ahmadvand D, Broom OJ (2012) Neutralization of human papillomavirus by specific nanobodies against major capsid protein L1 98. J Microbiol Biotechnol 22: 721-728. JMB022-05-20 [pii].
31. Muyldermans S, Atarhouch T, Saldanha J, Barbosa JA, Hamers R (1994) Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains. Protein Eng 7: 1129-1135. (Pubitemid 24282500)
32. Wesolowski J, Alzogaray V, Reyelt J, Unger M, Juarez K et al. (2009) Single domain antibodies: promising experimental and therapeutic tools in infection and immunity 6. Med Microbiol Immunol 198: 157-174. 10.1007/s00430-009-0116-7 [doi].
33. Khunrae P, Dahlback M, Nielsen MA, Andersen G, Ditlev SB et al. (2010) Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies. J Mol Biol 397: 826-834. S0022-2836(10)00086-0 [pii];10.1016/j.jmb.2010.01.040 [doi].
34. Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM et al. (2001) Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae 73. Antimicrob Agents Chemother 45: 2807-2812. 10.1128/AAC.45.10.2807-2812.2001 [doi]. (Pubitemid 32906675)
35. Hmila I, Abdallah RB, Saerens D, Benlasfar Z, Conrath K et al. (2008) VHH, bivalent domains and chimeric Heavy chain-only antibodies with high neutralizing efficacy for scorpion toxin AahI' 15. Mol Immunol 45: 3847-3856. S0161-5890(08)00161-2 [pii];10.1016/j.molimm.2008.04.011 [doi].
36. Stijlemans B, Caljon G, Natesan SK, Saerens D, Conrath K et al. (2011) High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis 30. PLoS Pathog 7: e1002072. 10.1371/journal.ppat.1002072 [doi];10-PLPA-RA-4101 [pii].
37. Nielsen MA, Resende M, Alifrangis M, Turner L, Hviid L et al. (2007) Plasmodium falciparum: VAR2CSA expressed during pregnancy-associated malaria is partially resistant to proteolytic cleavage by trypsin 103. Exp Parasitol 117: 1-8. S0014-4894(07)00076-8 [pii];10.1016/j.exppara.2007.03.002 [doi].